domingo, 20 de marzo de 2022

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study - The Lancet Infectious Diseases

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study - The Lancet Infectious Diseases

No hay comentarios:

Publicar un comentario